Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial.

Autor: Papp, Kathryn V., Rofael, H., Veroff, A. E., Donohue, M. C., Wang, S., Randolph, C., Grober, E., Brashear, H. Robert, Novak, G., Ernstrom, K., Raman, R., Aisen, P. S., Sperling, R., Romano, Gary, Henley, David
Zdroj: Journal of Prevention of Alzheimer's Disease; Apr2022, Vol. 9 Issue 2, p255-261, 7p
Databáze: Complementary Index
Externí odkaz: